PUBLICACIÓN
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
Gomez Garcia L.M. et al.
2021 Clinical Lymphoma, Myeloma and Leukemia
Cancer Research (Q3), Hematology (Q2), Oncology (Q2)
JCR: 2.822
SJR: 0.778
CITAS
10
DOI
10.1016/j.clml.2021.01.013
EID
2-s2.0-85101128565
ISSN
2152-2650
EISSN
2152-2669
AUTORES DE LA UEX